Chien-Ming Li

Chien-Ming Li is currently serving as the Director of Clinical Pharmacology and DMPK at Summit Therapeutics. Prior to this role, Chien-Ming held positions as a Principal Scientist at Pharmacyclics, a Senior Scientist at Global Blood Therapeutics, a Scientist at Optivia Biotechnology, and a Postdoctoral Researcher at UCSF. Chien-Ming's educational background includes a PhD in Pharmaceutical Sciences from The Ohio State University and a Master's degree in Analytical Chemistry from National Cheng Kung University.